Psychoneuroendocrinology
Volume 32, Issue 7 , Pages 843-853 , August 2007

Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression

  • Elizabeth A. Young

      Affiliations

    • Department of Psychiatry and Molecular and Behavioral Neurosciences Institute, University of Michigan, MBNI, 205 Zina Pitcher place, Ann Arbor, MI 48109-0720, USA
    • Corresponding Author InformationCorresponding author. Tel.: +17349362087; fax: +17346474130.
    • ,
  • Susan G. Kornstein

      Affiliations

    • Department of Psychiatry and Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, P.O. Box 980710, Richmond, VA 23298-0710, USA
    • ,
  • Anne T. Harvey

      Affiliations

    • Via Christi Research, Inc., 1100 N. St. Francis, Suite 300 Wichita, KS 67214, USA
    • ,
  • Stephen R. Wisniewski

      Affiliations

    • Epidemiology Data Center, GSPH, University of Pittsburgh, 127 Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    • ,
  • Jennifer Barkin

      Affiliations

    • Epidemiology Data Center, GSPH, University of Pittsburgh, 127 Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    • ,
  • Maurizio Fava

      Affiliations

    • Massachusetts General Hospital, 55 Fruit Street-Bulfinch 351, Boston, MA 02114, USA
    • ,
  • Madhukar H. Trivedi

      Affiliations

    • Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, 6363 Forest Park Road, Suite 13.354, Dallas, TX 75235, USA
    • ,
  • A. John Rush

      Affiliations

    • Departments of Clinical Sciences and Psychiatry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard Dallas, TX 75390-9066, USA

Received 20 February 2007 ,Revised 25 May 2007 ,Accepted 25 May 2007.

References 

  1. Abraham S, Luscombe G, Soo I. Oral contraception and cyclic changes in premenstrual and menstrual experiences. J. Psychosom. Obstet. Gynaecol. 2003;24:185–193
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (DSM-IV). Washington, DC: American Psychiatric Association Press, Inc.; 1994;
  3. Devidze N, Lee AW, Zhou J, Pfaff DW. CNS arousal mechanisms bearing on sex and other biologically regulated behaviors. Physiol. Behav. 2006;88:283–293
  4. Endicott, J., Nee, J., Harrison, W., Blumenthal, R., 1993. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol. Bull. 29321–29326.
  5. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiat. Clin. N. Am. 2003;26:457–494
  6. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol. Med. 2004;34:1299–1308
  7. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–933
  8. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiat. 1960;23:56–62
  9. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–296
  10. Herzberg BN, Johnson AL, Brown S. Depressive symptoms and oral contraceptives. Br. Med. J. 1970;4:142–145
  11. Joffe H, Cohen LS, Harlow BL. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Am. J. Obstet. Gynecol. 2003;189:1523–1528
  12. Khan AY, Carrithers J, Preskorn SH, Wisniewski SR, Lear R, Rush AJ, et al. Clinical and demographic factors associated With DSM-IV melancholic depression. Ann. Clin. Psychiat. 2006;18:91–98
  13. Kobak KA, Greist JH, Jefferson JW, Mundt JC, Katzelnick DJ. Computerized assessment of depression and anxiety over the telephone using interactive voice response. MD Comput. 1999;16:64–68
  14. Lawrie TA, Hofmeyr GJ, De Jager M, Berk M, Paiker J, Viljoen E. A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Br. J. Obstet. Gynaecol. 1998;105:1082–1090
  15. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J. Am. Geriat. Soc. 1968;16:622–626
  16. Masse PG, Van den Berg H, Livingstone MM, Duguay C, Beaulieu G. Nutritional and psychological status of young women after a short-term use of a triphasic contraceptive steroid preparation. Int. J. Vitam. Nutr. Res. 1998;68:203–207
  17. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiat. Res. 1992;41:237–248
  18. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol. Psychiat. 2004;55:406–412
  19. Mundt JC, Mareks IM, Shear K, Greist JH. The work and social adjustment scale (WSAS): a simple accurate measure of impairment in functioning. Br. J. Psychiat. 2002;180:461–464
  20. Nilson A, Almgren PE. Psychiatric symptoms during the post-partum period as related to oral contraceptives. Br. Med. J. 1968;2:453–455
  21. Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, Nierenberg A, et al. Clinical and demographic features of atypical depression in outpatients with major depression: preliminary findings from STAR*D. J. Clin. Psychiat. 2005;66:1002–1011
  22. O’Connell K, Davis JR, Kerns J. Oral contraceptives: side effects and depression in adolescent girls. Contraception. 2007;75:299–304
  23. Oinonen KA, Mazmanian D. To what extent do oral contraceptives influence mood and affect?. J. Affect. Disord. 2002;70:229–240
  24. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology. 2003;28:139–168
  25. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol. Med. 1996;26:477–486
  26. Rush AJ, Carmody T, Reimitz PE. The inventory of depressive symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int. J. Methods Psychiat. Res. 2000;9:45–59
  27. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-item inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS): a psychometric evaluation in patients with chronic major depression. Biol. Psychiat. 2003;54:573–583
  28. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi M, Sackeim HA, et al. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Rationale and design. Control. Clin. Trials. 2004;25:118–141
  29. Rush, A.J., Zimmerman, M., Wisniewski, S.R., Fava, M., Hollon, S.D., Warden, D., Biggs, M.M., Shores-Wilson, K., Shelton, R.C., Luther, J.F., Thomas, B., Trivedi, M.H., 2005. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J. Affect. Disorders 12, 87(1), 43–55.
  30. Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, et al. An evaluation of the quick inventory of depressive symptomatology and the Hamilton Rating Scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol. Psychiat. 2006;59:493–501
  31. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am. J. Obstet. Gynecol. 2000;183:414–420
  32. Shively CA, Bethea CL. Cognition, mood disorders, and sex hormones. ILAR J. 2004;45:189–199
  33. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch. Gen. Psychiat. 2001;58:529–534
  34. Sugar CA, Sturm R, Lee TT, et al. Empirically defined health states for depression from the SF-12. Health Serv. Res. 1998;33(4 Part 1):911–928
  35. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs M, M. Suppes T, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol. Med. 2004;34:73–82
  36. Ware JE, Kosinksi M, Keller S. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med. Care. 1996;34:220–233
  37. Westhoff C, Truman C, Kalmuss D, Cushman L, Rulin M, Heartwell S, et al. Depressive symptoms and Norplant contraceptive implants. Contraception. 1998;57:241–245
  38. Westhoff C, Truman C, Kalmuss D, Cushman L, Davidson A, Rulin M, et al. Depressive symptoms and depo-provera. Contraception. 1998;57:237–240
  39. Worsley A, Change A. Oral contraceptive and emotional states. J. Psychosom. Res. 1978;22:13–16
  40. Young EA, Korszun A, Altemus M. Sex differences in neuroendocrine and neurotransmitter Systems. In:  Kornstein S,  Clayton A editor. Women's Mental Health, A Comprehensive Textbook. New York: Guilford Press; 2002;p. 3–30
  41. Zimmerman M, Mattia JI. The reliability and validity of a screening questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J. Clin. Psychiat. 1999;60:677–683

PII: S0306-4530(07)00123-0

doi: 10.1016/j.psyneuen.2007.05.013

Psychoneuroendocrinology
Volume 32, Issue 7 , Pages 843-853 , August 2007

Article Tools

* Image Usage & Resolution